Wedbush analyst Alicia Brondolo maintained an Outperform rating and boosted the price target from $725 to $745 on Oct. 6, 2025. This analyst has an accuracy rate of 70%. Citigroup analyst Jason ...

Beijing has reportedly issued a directive banning foreign AI chips in state-funded data centers amid an intensifying U.S.-China tech war.

Novo Nordisk Q3 profit drops on restructuring costs as GLP-1 and obesity drug sales rise; company narrows 2025 growth outlook.

In the assessment of 12-month price targets, analysts unveil insights for Advanced Micro Devices, presenting an average ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $182.44, a high estimate of $200 ...

Piper Sandler analyst Rob Owens upgraded Qualys, Inc. (NASDAQ: QLYS) from Underweight to Neutral and raised the price target ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $30.67, a high estimate of $39.00, ...

Mirum Pharmaceuticals (NASDAQ: MIRM) has been analyzed by 6 analysts in the last three months, revealing a diverse range of ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $94.3, with a high ...

Across the recent three months, 10 analysts have shared their insights on Kymera Therapeutics (NASDAQ: KYMR ), expressing a ...

U.S. stock futures were fluctuating on Wednesday after Tuesday’s lower close. Futures of major benchmark indices were mixed.

On its first day of trading, Beta Technologies (NYSE: BETA) has made a remarkable debut, raising $1 billion and closing in the green.